2m 2m 2m 2m 2m 2m 2m
Alnylam Pharma (ALNY)
NASDAQ
$290.25+$2.07 (+0.72%)
Price as of Jun 24, 2026 6:30 PM EDT- $38.5BMarket Cap
- -11.33%1-Year Change
- BiotechnologyIndustry
Alnylam Pharma (ALNY)
$290.25+$2.07 (+0.72%)
ALNY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $288.18 | ||
Change | +$1.77 (+0.62%) | ||
Open | $290.89 | ||
High | $291.95 | ||
Low | $285.26 | ||
Previous Close | $286.41 | ||
Volume | 1,087,827 | ||
30-Day Average Volume | 1,228,452 | ||
1-Week Change | 2.23% | ||
1-Month Change | -3.12% | ||
1-Year Change | -11.33% | ||
3-Year Change | 49.56% | ||
5-Year Change | 65.02% | ||
Fundamentals | |||
Shares Outstanding | 133.5M | ||
Total Assets | $5.1B | ||
Market Cap | $38.5B | ||
Enterprise Value | $37.8B | ||
Period: QTR TTM FY | |||
Revenue | $1.0B | ||
Net Income | $206.0M | ||
Free Cash Flow | $48.7M | ||
EBIT | $221.7M | ||
EBITDA | $235.2M | ||
Net Working Capital | $2.9B | ||
EPS | $1.51 | ||
Enterprise Value/EBITDA | 161 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 36 | ||
P/E | 191 | ||
PEG | 13 | ||
Price/Free Cash Flow | 791 | ||
Price/Operating Cash Flow | 546 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue